Member Info for Tambo210

Shame they're not presenting at the JPM conference this year. PacBio just made a crucial announcement yesterday and will back it up with a fireside chat there.

Liberum reinitiates Morgan Advanced Materials with 'buy' - price target 400 penc

Shame about today's RNS regarding the cyber attack. Wonder who would pick on them and why? If its anything IP related, I'd say that's bullish.

Anyway, hopefully it'll give management and IT a kick up the @rse and get that firewall sorted.

Deutsche Bank cuts Legal & General to 'hold' (buy) - price target 290 pence

He's resigned

JPMorgan raises Ferrexpo price target to 140 (110) pence - 'neutral'

MRNA up 24% as I type.

The drugmaker announced that its experimental melanoma vaccine combined with Merck
(MRK) cancer treatment Keytruda cut the risk of skin cancer recurrence by 44% compared with a treatment of only Keytruda. Moderna rallied 7.5% in the premarket, while Merck gained 1.9%.

NAV is down 1% or so.

Today and tomorrow (possibly Thursday) are going to be interesting on the US markets. Could go either way.

Brookline capital just put a $500+ price target on MRNA as of yesterday.

Next week is going to be pretty volatile for the NAV.
CPI numbers on Tuesday and the Fed decision on Wednesday.
If CPI comes in higher, then expect holding of SMT to tank with the expectation of more meaty hikes in FED rates.
If we see another drop like the one in October, then Stocks will rally. If on the back of that, the FED only raises rates by 50bps, then we'll get another bump and then I'd say a few more days of a customary Santa Rally.

Tuesday + Wednesday are going to tense!.

Bank of America raises Legal & General price target to 274 (265) pence - 'neutral'

Cash and cash equivalents of £471.6 million and treasury deposits of £131.0 million, decreased
by £15.5 million over HY22, due to operating losses partially offset by increased LSRT gross
profit and cash proceeds from the DHSC settlement.

You're right in that the last half didn't show much movement in liquidity. But its the cash flow from ops which is king. Don't want to be raising cash through dilution.

You know, if cash flow wasn't ever going to be a concern, why are they only going to reach EBITDA neutral by 2026? WHy not earlier? Gross Margins too low?

RNS stated they bought back over 900k of the ordinary stock to be held in treasury.
Nice.

"390p SP early next year is easily achieveable.....1 for 2 share consolidation (which means it might even reach £5)!!!"

LOL! Reverse split? No threat of delisting here. Volatility is quite low too.

There you have it, nice bump in NAV.
PMI numbers out today, which may reinforce the arguments to be less aggressive on rates, hopefully lowering yields.

Most of their top holding rose materially yesterday, so I'd expect the NAV to track that. MRNA was only 1pc up or so at close.
TSLA was up 7pc, ASML and ILMN were up 4pc.
Of course, SP might decide to do the opposite and widen the discount.
Fingers crossed Powell only gives a 50bps rise in rates in Dec. 13th Dec is when the next CPI numbers are out. FED decides interest rate on 14th.
Bah humbug

@Nick1234
When you look at the SP over the last 10 years, All time high is something like 310p.
Won't reach 397p in 12months. They'd need bumper growth (probably through acquisitions)

Its more of a dividend stock. If they materially reduced the float, then perhaps it would help, but its a reliable income stock.
Plot the chart over 10y, and you'll see it barely rose above 3. Why would it jump to £3.90?

Compared with PACBIO, ONT really hasn't offered the markets something exciting to raise its image.
IPO is long gone and the SP has deflated. Still burning cash. Probably another dilution on the cards.
Whilst I'd be tempted to buy another 1k shares, the dilution threat is still there.
FX is going to be a thorn just like others have commented, though if you're in the US, buying consumables and their ION kits has never been cheaper. So ironically it could turn out to be a blessing.

30-Nov-22 Barclays Overweight 397.00 397.00 Reiteration